Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Moch

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Der Pathologe|June 5, 2013
[Thyroid-like follicular carcinoma of the kidney: a separate tumor entity?]S Berens, P Vogt, H Alkadhi, et al.
Der Urologe. Ausg. A|November 12, 2015
[Leiomyomatous renal cell carcinoma : Controversy around a new entity]S Rausch, M Scharpf, H Moch, et al.
European Urology|June 6, 1998
Molecular cytogenetics of bladder cancer progressionG Sauter, H Moch, M J Mihatsch, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 26, 2010
Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomasS Schmid, M Tinguely, P Cione, et al.
Der Pathologe|January 13, 1999
[Epithelioid angiomyolipoma of the kidney--a new tumor entity. Case report on a tumor with many multinucleated giant cells]H Moch, O M Braun, L Terracciano, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1993
Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findingsH Moch, M Oberholzer, P Dalquen, et al.
Der Pathologe|September 24, 2008
Immunophenotyping without antibodies. New perspectives for lymphoma characterizationM Tinguely, A Hofmann, D Bausch-Fluck, et al.
Der Pathologe|October 29, 2009
[Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses]G Boysen, B Wollscheid, D Bausch-Fluck, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1993
[Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors]H Moch, G Sauter, F Gudat, et al.
Journal of Clinical Pathology|May 29, 2004
CDX-2 immunostaining in primary and secondary ovarian carcinomasL Tornillo, H Moch, P-A Diener, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Der Pathologe|June 5, 2013
[Thyroid-like follicular carcinoma of the kidney: a separate tumor entity?]S Berens, P Vogt, H Alkadhi, et al.
Der Urologe. Ausg. A|November 12, 2015
[Leiomyomatous renal cell carcinoma : Controversy around a new entity]S Rausch, M Scharpf, H Moch, et al.
European Urology|June 6, 1998
Molecular cytogenetics of bladder cancer progressionG Sauter, H Moch, M J Mihatsch, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 26, 2010
Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomasS Schmid, M Tinguely, P Cione, et al.
Der Pathologe|January 13, 1999
[Epithelioid angiomyolipoma of the kidney--a new tumor entity. Case report on a tumor with many multinucleated giant cells]H Moch, O M Braun, L Terracciano, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1993
Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findingsH Moch, M Oberholzer, P Dalquen, et al.
Der Pathologe|September 24, 2008
Immunophenotyping without antibodies. New perspectives for lymphoma characterizationM Tinguely, A Hofmann, D Bausch-Fluck, et al.
Der Pathologe|October 29, 2009
[Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses]G Boysen, B Wollscheid, D Bausch-Fluck, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1993
[Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors]H Moch, G Sauter, F Gudat, et al.
Journal of Clinical Pathology|May 29, 2004
CDX-2 immunostaining in primary and secondary ovarian carcinomasL Tornillo, H Moch, P-A Diener, et al.
Pageof 19